Display options
Cite
Park S, Zhu J, Altan-Bonnet G, et al. Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model. Am J Cancer Res. 2019;9(7):1439-1453
Park, S., Zhu, J., Altan-Bonnet, G., & Cheng, S. Y. (2019). Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model. American journal of cancer research, 9(7), 1439-1453.
Park, Sunmi, et al. "Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model." American journal of cancer research vol. 9,7 (2019): 1439-1453.
Park S, Zhu J, Altan-Bonnet G, Cheng SY. Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model. Am J Cancer Res. 2019 Jul 01;9(7):1439-1453. eCollection 2019. PMID: 31392080; PMCID: PMC6682719.
Copy Download .nbib Format: NLM
Share it on

Am J Cancer Res. 2019 Jul 01;9(7):1439-1453. eCollection 2019.

Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model.

American journal of cancer research

Sunmi Park, Jack Zhu, Grégoire Altan-Bonnet, Sheue-Yann Cheng

Affiliations

  1. Laboratory of Molecular Biology, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute Bethesda, Maryland 20892-4264, USA.
  2. Cancer Genetics Branch, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute Bethesda, Maryland 20892-4264, USA.
  3. Immunodynamics Group, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute Bethesda, Maryland 20892-4264, USA.

PMID: 31392080 PMCID: PMC6682719

Abstract

Thyroid cancer is the most common endocrine malignancy. Although an association between inflammation and thyroid cancer has long been recognized, a cause-effect relationship at the molecular level has yet to be elucidated. We explored how inflammation could contribute to thyroid carcinogenesis in

Keywords: AKT signaling; Inflammation; activated monocytes; apoptosis; cDNA microarrays; integrins; osteopontin; thyroid cancer

Conflict of interest statement

None.

References

  1. Lancet. 2001 Feb 17;357(9255):539-45 - PubMed
  2. J Biol Chem. 2001 Apr 20;276(16):13483-9 - PubMed
  3. J Clin Invest. 2001 May;107(9):1055-61 - PubMed
  4. J Biol Chem. 2001 Jul 27;276(30):28261-7 - PubMed
  5. J Biol Chem. 2001 Dec 7;276(49):46024-30 - PubMed
  6. Clin Cancer Res. 2001 Dec;7(12):4060-6 - PubMed
  7. J Leukoc Biol. 2002 Oct;72(4):752-61 - PubMed
  8. Nature. 2002 Dec 19-26;420(6917):860-7 - PubMed
  9. Chir Ital. 2003 May-Jun;55(3):365-72 - PubMed
  10. J Clin Endocrinol Metab. 2003 Sep;88(9):4418-25 - PubMed
  11. J Clin Invest. 2003 Nov;112(9):1318-31 - PubMed
  12. J Bone Miner Res. 2004 Jan;19(1):78-88 - PubMed
  13. Br J Cancer. 2004 May 17;90(10):1877-81 - PubMed
  14. Lung. 2004;182(3):173-85 - PubMed
  15. Curr Opin Immunol. 2006 Feb;18(1):49-53 - PubMed
  16. Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1780-5 - PubMed
  17. Cancer Res. 2006 Jul 1;66(13):6638-48 - PubMed
  18. J Clin Endocrinol Metab. 2007 Jun;92(6):2387-90 - PubMed
  19. Thyroid. 2007 May;17(5):389-93 - PubMed
  20. Mol Cell Biol. 2007 Sep;27(17):6116-26 - PubMed
  21. Carcinogenesis. 2007 Dec;28(12):2451-8 - PubMed
  22. Eur J Endocrinol. 2007 Sep;157(3):325-9 - PubMed
  23. Nature. 2008 Jul 24;454(7203):436-44 - PubMed
  24. Endocr Relat Cancer. 2008 Dec;15(4):1069-74 - PubMed
  25. Oncogene. 2009 Jan 29;28(4):509-17 - PubMed
  26. Annu Rev Immunol. 2009;27:669-92 - PubMed
  27. Carcinogenesis. 2009 Jul;30(7):1073-81 - PubMed
  28. Blood. 2010 Jan 21;115(3):e10-9 - PubMed
  29. J Clin Endocrinol Metab. 2010 May;95(5):2325-33 - PubMed
  30. Thyroid. 2010 Jul;20(7):697-706 - PubMed
  31. J Cell Mol Med. 2010 Aug;14(8):2037-44 - PubMed
  32. PLoS One. 2011;6(7):e22567 - PubMed
  33. Immunity. 2013 Sep 19;39(3):599-610 - PubMed
  34. Neoplasia. 2014 Sep;16(9):757-69 - PubMed
  35. Curr Opin Oncol. 2015 Jan;27(1):21-5 - PubMed
  36. Endocr Relat Cancer. 2016 Jan;23(1):53-63 - PubMed
  37. J Clin Invest. 2016 Mar 1;126(3):1052-66 - PubMed
  38. Mediators Inflamm. 2016;2016:6058147 - PubMed
  39. Clin Colorectal Cancer. 2016 Sep;15(3):204-12 - PubMed
  40. Oncotarget. 2016 Jun 21;7(25):38707-38717 - PubMed
  41. Clin Cancer Res. 2018 Jul 1;24(13):3059-3068 - PubMed
  42. Cell Res. 2018 Jul;28(7):701-718 - PubMed
  43. Endocr Relat Cancer. 2018 Oct;25(10):865-877 - PubMed
  44. Endocrinol Metab (Seoul). 2019 Mar;34(1):11-22 - PubMed
  45. J Clin Endocrinol Metab. 1995 Dec;80(12):3421-4 - PubMed
  46. J Biol Chem. 1996 Nov 8;271(45):28485-91 - PubMed
  47. Int J Cancer. 1998 Oct 23;79(5):502-8 - PubMed
  48. Cancer Res. 1999 Jan 1;59(1):219-26 - PubMed

Publication Types